Although YKL-40 has been proposed to be a new marker of inflammation, atherosclerosis and endothelial dysfunction in neoplastic, cardiovascular and metabolic diseases, it has not been studied in the context of essential hypertension . The gene discussed is CHI3L1; the disease is hypertensive disorder.